Vera Therapeutics Inc. (VERA)
20.99
-0.60 (-2.78%)
At close: Apr 16, 2025, 11:14 AM
Company Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States.
Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy.
It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial.
The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020.
Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Vera Therapeutics Inc.
| Country | United States |
| IPO Date | May 14, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 112 |
| CEO | Dr. Marshall W. Fordyce M.D. |
Contact Details
Address: 8000 Marina Boulevard Brisbane, California United States | |
| Website | https://veratx.com |
Stock Details
| Ticker Symbol | VERA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001831828 |
| CUSIP Number | 92337R101 |
| ISIN Number | US92337R1014 |
| Employer ID | 81-2744449 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Marshall W. Fordyce M.D. | Founder, President, Chief Executive Officer & Director |
| Jason S. Carter | Chief Legal Officer |
| Sean P. Grant M.B.A. | Chief Financial Officer |
| David L. Johnson M.B.A. | Chief Opearating Officer |
| Debra Charlesworth | Vice President of Corporate Communications |
| Dr. Allen Ebens B.Sc., Ph.D. | Executive Vice President of Research |
| Dr. Robert M. Brenner M.D. | Chief Medical Officer |
| Emma Haywood | Vice President of Marketing |
| Joseph R. Young M.B.A. | Senior Vice President of Finance & Chief Accounting Officer |
| Kelly Rauber | Senior Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 03, 2025 | ARS | Filing |
| Apr 03, 2025 | DEFA14A | Filing |
| Apr 03, 2025 | DEF 14A | Filing |
| Feb 28, 2025 | S-8 | Filing |
| Feb 28, 2025 | 10-K | Annual Report |
| Feb 27, 2025 | 4 | Filing |
| Feb 26, 2025 | 8-K | Current Report |
| Feb 20, 2025 | 4 | Filing |
| Feb 20, 2025 | 4 | Filing |
| Feb 20, 2025 | 4 | Filing |